|
ORC1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.19750020799847E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.614020E-04 |
| Normal-vs-Stage2 |
7.186500E-02 |
| Normal-vs-Stage3 |
6.43639999999834E-05 |
| Normal-vs-Stage4 |
3.496400E-02 |
| Stage1-vs-Stage2 |
3.331600E-01 |
| Stage1-vs-Stage3 |
1.343790E-03 |
| Stage1-vs-Stage4 |
1.029830E-01 |
| Stage2-vs-Stage3 |
1.302200E-01 |
| Stage2-vs-Stage4 |
3.698200E-01 |
| Stage3-vs-Stage4 |
7.937200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.05079999835579E-08 |
| Normal-vs-AfricanAmerican |
3.234800E-04 |
| Normal-vs-Asian |
1.753020E-01 |
| Caucasian-vs-AfricanAmerican |
5.551000E-01 |
| Caucasian-vs-Asian |
2.268800E-01 |
| AfricanAmerican-vs-Asian |
3.792400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.0943000000061E-06 |
| Normal-vs-Female |
2.23020000023055E-07 |
| Male-vs-Female |
1.158150E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.034900E-04 |
| Normal-vs-Extreme_Weight |
7.784200E-03 |
| Normal-vs-Obese |
1.614000E-04 |
| Normal-vs-Extreme_Obese |
2.940800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.620300E-02 |
| Normal_Weight-vs-Obese |
8.772800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.897800E-02 |
| Extreme_Weight-vs-Obese |
6.219900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.067400E-01 |
| Obese-vs-Extreme_Obese |
6.104000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.018100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.84370000044787E-07 |
| Normal-vs-Age(61-80Yrs) |
9.82250000000073E-05 |
| Normal-vs-Age(81-100Yrs) |
1.232030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.140840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.598400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.441500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.697900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.800800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.268800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.42039999999566E-05 |
| Normal-VS-Type2 PRCC |
6.27500000000003E-05 |
| Normal-VS-KIRP CIMP |
1.802540E-03 |
| Normal-VS-Unclassified PRCC |
7.185200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.732100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.976200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.196400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.300000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.695790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.222200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.477130E-03 |
| Normal-vs-N1 |
2.192100E-04 |
| Normal-vs-N2 |
1.756780E-01 |
| N0-vs-N1 |
1.046110E-02 |
| N0-vs-N2 |
2.761600E-01 |
| N1-vs-N2 |
5.687800E-01 |
|
|
